FDA Drug Application (021162) for MICARDIS HCT by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number021162
Product Number001
FormTABLET;ORAL
Dosage12.5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMICARDIS HCT
Active IngredientHYDROCHLOROTHIAZIDE; TELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM